Jordan T Lloyd , Andrew V. Collins , John R Phillips , Monica L. Acosta
{"title":"阿托品在离体实验鸡近视模型中恢复视网膜谷氨酸/ γ-氨基丁酸水平","authors":"Jordan T Lloyd , Andrew V. Collins , John R Phillips , Monica L. Acosta","doi":"10.1016/j.visres.2025.108656","DOIUrl":null,"url":null,"abstract":"<div><div>Atropine is widely used to slow childhood myopia progression, but its mechanisms of action remain poorly understood. This study investigated atropine’s effects on retinal neurochemistry in a chick model of form-deprivation myopia (FDM). Myopia was induced in chicks via monocular FDM. Retinas from FDM and contralateral normal eyes were enucleated, bisected and six retinal samples per group were incubated for 60 min in vitro in either 1.8 mM atropine or normal physiological buffer. Samples were fixed in glutaraldehyde for neurotransmitter detection using silver-intensified immunogold labelling. In a separate experiment, the incubation procedure of FDM and normal eyes was repeated and tissues were fixed in formaldehyde to examine dopaminergic neurons using tyrosine hydroxylase (TH) immunofluorescence.</div><div>No significant changes in TH immunolabelling were observed between groups. However, myopia reduced glutamate levels by 43% compared to controls, with altered glutamate distribution in the inner retina. Bipolar cells in myopic eyes also showed a 57% decrease in glutamine levels. Within 60 min, atropine treatment restored both glutamate and glutamine levels toward normal levels. The most noteworthy changes to gamma aminobutyric acid (GABA) was a 62% reduction observed in the outer plexiform layer (OPL) between normal and myopic retinas. Following atropine treatment, there was a further decrease in (GABA) levels in OPL and horizontal cells.</div><div>These findings suggest that one immediate effect of atropine treatment is to restore the balance of neurotransmitters that are disrupted in myopia, elevating glutamate while reducing GABA. This neurotransmitter modulation may contribute to atropine’s therapeutic effects in myopia control.</div></div>","PeriodicalId":23670,"journal":{"name":"Vision Research","volume":"234 ","pages":"Article 108656"},"PeriodicalIF":1.4000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Atropine restores retinal glutamate / γ-aminobutyric acid levels in vitro in an experimental chick model of myopia\",\"authors\":\"Jordan T Lloyd , Andrew V. Collins , John R Phillips , Monica L. Acosta\",\"doi\":\"10.1016/j.visres.2025.108656\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Atropine is widely used to slow childhood myopia progression, but its mechanisms of action remain poorly understood. This study investigated atropine’s effects on retinal neurochemistry in a chick model of form-deprivation myopia (FDM). Myopia was induced in chicks via monocular FDM. Retinas from FDM and contralateral normal eyes were enucleated, bisected and six retinal samples per group were incubated for 60 min in vitro in either 1.8 mM atropine or normal physiological buffer. Samples were fixed in glutaraldehyde for neurotransmitter detection using silver-intensified immunogold labelling. In a separate experiment, the incubation procedure of FDM and normal eyes was repeated and tissues were fixed in formaldehyde to examine dopaminergic neurons using tyrosine hydroxylase (TH) immunofluorescence.</div><div>No significant changes in TH immunolabelling were observed between groups. However, myopia reduced glutamate levels by 43% compared to controls, with altered glutamate distribution in the inner retina. Bipolar cells in myopic eyes also showed a 57% decrease in glutamine levels. Within 60 min, atropine treatment restored both glutamate and glutamine levels toward normal levels. The most noteworthy changes to gamma aminobutyric acid (GABA) was a 62% reduction observed in the outer plexiform layer (OPL) between normal and myopic retinas. Following atropine treatment, there was a further decrease in (GABA) levels in OPL and horizontal cells.</div><div>These findings suggest that one immediate effect of atropine treatment is to restore the balance of neurotransmitters that are disrupted in myopia, elevating glutamate while reducing GABA. This neurotransmitter modulation may contribute to atropine’s therapeutic effects in myopia control.</div></div>\",\"PeriodicalId\":23670,\"journal\":{\"name\":\"Vision Research\",\"volume\":\"234 \",\"pages\":\"Article 108656\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vision Research\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0042698925001178\",\"RegionNum\":4,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vision Research","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0042698925001178","RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Atropine restores retinal glutamate / γ-aminobutyric acid levels in vitro in an experimental chick model of myopia
Atropine is widely used to slow childhood myopia progression, but its mechanisms of action remain poorly understood. This study investigated atropine’s effects on retinal neurochemistry in a chick model of form-deprivation myopia (FDM). Myopia was induced in chicks via monocular FDM. Retinas from FDM and contralateral normal eyes were enucleated, bisected and six retinal samples per group were incubated for 60 min in vitro in either 1.8 mM atropine or normal physiological buffer. Samples were fixed in glutaraldehyde for neurotransmitter detection using silver-intensified immunogold labelling. In a separate experiment, the incubation procedure of FDM and normal eyes was repeated and tissues were fixed in formaldehyde to examine dopaminergic neurons using tyrosine hydroxylase (TH) immunofluorescence.
No significant changes in TH immunolabelling were observed between groups. However, myopia reduced glutamate levels by 43% compared to controls, with altered glutamate distribution in the inner retina. Bipolar cells in myopic eyes also showed a 57% decrease in glutamine levels. Within 60 min, atropine treatment restored both glutamate and glutamine levels toward normal levels. The most noteworthy changes to gamma aminobutyric acid (GABA) was a 62% reduction observed in the outer plexiform layer (OPL) between normal and myopic retinas. Following atropine treatment, there was a further decrease in (GABA) levels in OPL and horizontal cells.
These findings suggest that one immediate effect of atropine treatment is to restore the balance of neurotransmitters that are disrupted in myopia, elevating glutamate while reducing GABA. This neurotransmitter modulation may contribute to atropine’s therapeutic effects in myopia control.
期刊介绍:
Vision Research is a journal devoted to the functional aspects of human, vertebrate and invertebrate vision and publishes experimental and observational studies, reviews, and theoretical and computational analyses. Vision Research also publishes clinical studies relevant to normal visual function and basic research relevant to visual dysfunction or its clinical investigation. Functional aspects of vision is interpreted broadly, ranging from molecular and cellular function to perception and behavior. Detailed descriptions are encouraged but enough introductory background should be included for non-specialists. Theoretical and computational papers should give a sense of order to the facts or point to new verifiable observations. Papers dealing with questions in the history of vision science should stress the development of ideas in the field.